Michael York
No más puestos en curso
Fortuna: 59 629 $ al 31/05/2023
Historial de carrera de Michael York
Antiguos cargos conocidos de Michael York.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| METACRINE, INC. | Comptroller/Controller/Auditor | 31/03/2022 | 24/03/2023 |
| Director Ejecutivo | 01/02/2023 | 24/03/2023 | |
| Director Financiero/CFO | 31/03/2022 | 24/03/2023 | |
| Corporate Officer/Principal | 01/12/2021 | 31/03/2022 | |
| Presidente | 01/02/2023 | 24/03/2023 | |
| Secretario Corporativo | 01/02/2023 | 24/03/2023 | |
| Treasurer | 31/03/2022 | 24/03/2023 | |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2018 | 01/11/2021 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2015 | 01/06/2018 |
| Sente, Inc. | Director Ejecutivo | 01/07/2013 | 01/12/2014 |
| Presidente | 01/07/2013 | 01/12/2014 | |
| SENTÉ Labs | Director Ejecutivo | - | - |
| Presidente | - | - | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formación de Michael York.
| University of Redlands | Masters Business Admin |
| San Diego State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Sente, Inc. | Technology Services |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
| SENTÉ Labs |
- Bolsa de valores
- Insiders
- Michael York
- Experiencia
